Non-expedited Cases To US FDA Are Appearing In The 15 Day Alert Section In NDA Report
(Doc ID 2869712.1)
Last updated on DECEMBER 04, 2023
Applies to:Oracle Life Sciences Argus Safety - Version 8.2.3 and later
Information in this document applies to any platform.
The following request was proposed as an enhancement to NDA Periodic reporting.
The NDA periodic (and other periodic reports as appropriate) should reflect the fact that non-expedited ICSRs submitted by companies on a rolling basis are
not 15 day alerts and are not classified as such.
The suggestion includes the ability to identify these as non-expedited reports and exclude them from the 15D alerts listing.
To view full details, sign in with your My Oracle Support account.
Don't have a My Oracle Support account? Click to get started!
In this Document